Novel heterotypic cell cultures for liver toxicology studies

用于肝毒理学研究的新型异型细胞培养物

基本信息

  • 批准号:
    8054693
  • 负责人:
  • 金额:
    $ 22.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-01 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of our proposal is to investigate paracrine fibrogenic signaling between parenchymal and non parenchymal liver cells during alcohol injury. Whereas the nonparenchymalcompartment (stellate cells) remains the major player in the development of liver, the role of the parenchymal cells (hepatocytes) in this process is drawing increasing attention. Improved understanding of the roles played by parenchymal and nonparenchymalliver cells during alcohol insult will translate into better, more effective and targeted therapeutics. However, the complex signaling exchange between different liver cell types is difficult to delineate with in vivo models or standard in vitro cell culture approaches. In this proposal, we will utilize a novel liver cell culture approach to investigate !he hypothesis that hepatic production of transforming growth factor (TGF)-¿ plays an important role in initiating the fibrogneic program of stellate cells. This hypothesis will be explored using a novel cell culture system where cell adhesive and/or signaling molecules are imprinted into a culture substrate so as to position discrete groups of hepatocytes and stellate cells in defined locations and in close proximity to each other (see Figure 1 (A,B)). As shown in Figure 1 C, this novel cell culture dish will be used to selectively stimulate hepatocytes within the co-cultures with anti-fibrotic growth factors (GFs) (e.g. HGF and BMP7) during alcohol injury in order to investigate how GF signals delivered to hepatocytes impact activation of neighboring stellate cells. The novelty of the proposed platform lies in our ability to define interactions of two liver cell types cultured in the same dish so as to modulate the phenotype of one cell type and to study the response of the other cell type. This approach is particularly well-suited for improving our understanding of the complex heterotypic signaling underlying liver fibrosis. The novel cell culture system described here is envisioned as an enabling technology for liver toxicology studies and for high-throughput screening of liver-protective molecules. PUBLIC HEALTH RELEVANCE: Liver is the metabolic center of the human body and is largely responsible for carrying out detoxification functions in the body. Consumption of alcohol has an adverse effect on the liver and can lead to liver dysfunction. We are developing novel liver cell culture in order to better understand effects of alcohol on the liver and to enable development of liver-protective therapies.
描述(由申请人提供):我们建议的目的是研究酒精损伤期间肝实质和非实质细胞之间的旁分泌纤维化信号传导。虽然非实质隔室(星状细胞)仍然是肝脏发育的主要参与者,但实质细胞(肝细胞)在这一过程中的作用正引起越来越多的关注。对实质和非实质肝细胞在酒精损伤过程中所起作用的进一步理解将转化为更好,更有效和更有针对性的治疗方法。然而,不同肝细胞类型之间的复杂信号交换难以用体内模型或标准体外细胞培养方法描绘。在本提案中,我们将利用一种新的肝细胞培养方法进行研究!肝转化生长因子(TGF-β)的产生在启动星状细胞的纤维生成过程中起重要作用的假说。将使用一种新型细胞培养系统探索该假设,其中将细胞粘附和/或信号传导分子印迹到培养基质中,以便将离散的肝细胞和星状细胞组定位在确定的位置并彼此紧密接近(参见图1(A,B))。如图1C所示,该新型细胞培养皿将用于在酒精损伤期间选择性刺激具有抗纤维化生长因子(GF)(例如HGF和BMP 7)的共培养物内的肝细胞,以研究递送至肝细胞的GF信号如何影响邻近星状细胞的活化。所提出的平台的新奇在于我们能够定义在同一培养皿中培养的两种肝细胞类型的相互作用,以便调节一种细胞类型的表型并研究另一种细胞类型的反应。这种方法特别适合于提高我们对肝纤维化基础上的复杂异型信号传导的理解。这里描述的新型细胞培养系统被设想为用于肝脏毒理学研究和用于肝脏保护分子的高通量筛选的使能技术。 公共卫生相关性:肝脏是人体的代谢中心,在很大程度上负责执行体内的解毒功能。饮酒对肝脏有不良影响,可能导致肝功能障碍。我们正在开发新的肝细胞培养,以更好地了解酒精对肝脏的影响,并开发肝脏保护疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander Revzin其他文献

Alexander Revzin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander Revzin', 18)}}的其他基金

Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases
用于肝脏疾病细胞外囊泡高灵敏度和样品节省分析的质谱法
  • 批准号:
    10736006
  • 财政年份:
    2023
  • 资助金额:
    $ 22.27万
  • 项目类别:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
用于个性化胰腺癌治疗的微流控细胞培养平台
  • 批准号:
    9882916
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
用于个性化胰腺癌治疗的微流控细胞培养平台
  • 批准号:
    10155447
  • 财政年份:
    2020
  • 资助金额:
    $ 22.27万
  • 项目类别:
Context rich mass spectrometry of molecular localization and cellular interactions
分子定位和细胞相互作用的上下文丰富质谱分析
  • 批准号:
    9751908
  • 财政年份:
    2017
  • 资助金额:
    $ 22.27万
  • 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
  • 批准号:
    9215666
  • 财政年份:
    2016
  • 资助金额:
    $ 22.27万
  • 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
  • 批准号:
    9889953
  • 财政年份:
    2016
  • 资助金额:
    $ 22.27万
  • 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
  • 批准号:
    9412328
  • 财政年份:
    2016
  • 资助金额:
    $ 22.27万
  • 项目类别:
Novel heterotypic cell cultures for liver toxicology studies
用于肝毒理学研究的新型异型细胞培养物
  • 批准号:
    8323544
  • 财政年份:
    2011
  • 资助金额:
    $ 22.27万
  • 项目类别:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
设计 hESC 肝脏特异性分化的微环境
  • 批准号:
    8448619
  • 财政年份:
    2010
  • 资助金额:
    $ 22.27万
  • 项目类别:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
设计 hESC 肝脏特异性分化的微环境
  • 批准号:
    8066334
  • 财政年份:
    2010
  • 资助金额:
    $ 22.27万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 22.27万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 22.27万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了